ABSTRACT
Painful conditions and sleep disturbances are major public health problems worldwide and one directly affects the other. Sleep loss increases pain prevalence and severity; while pain disturbs sleep. However, the underlying mechanisms are largely unknown. Here we asked whether chronic sleep restriction for 6â¯h daily progressively increases pain sensitivity and if this increase is reversed after two days of free sleep. Also, whether the pronociceptive effect of chronic sleep restriction depends on the periaqueductal grey and on the nucleus accumbens, two key regions involved in the modulation of pain and sleep-wake cycle. We showed that sleep restriction induces a pronociceptive effect characterized by a significant decrease in the mechanical paw withdrawal threshold in rats. Such effect increases progressively from day 3 to day 12 remaining stable thereafter until day 26. Two consecutive days of free sleep were not enough to reverse the effect, not even to attenuate it. This pronociceptive effect depends on the periaqueductal grey and on the nucleus accumbens, since it was prevented by their excitotoxic lesion. Complementarily, chronic sleep restriction significantly increased c-Fos protein expression within the periaqueductal grey and the nucleus accumbens and this correlates with the intensity of the pronociceptive effect, suggesting that the greater the neural activity in this regions, the greater the effect. These findings may contribute not only to understand why painful conditions are more prevalent and severe among people who sleep poorly, but also to develop therapeutic strategies to prevent this, increasing the effectiveness of pain management in this population.
Subject(s)
Nucleus Accumbens/physiopathology , Pain Perception/physiology , Pain Threshold/physiology , Periaqueductal Gray/physiopathology , Sleep Deprivation/physiopathology , Animals , Male , N-Methylaspartate/toxicity , Nociceptive Pain/pathology , Nociceptive Pain/physiopathology , Nucleus Accumbens/pathology , Periaqueductal Gray/pathology , Proto-Oncogene Proteins c-fos/metabolism , Rats, Wistar , Sleep Deprivation/pathology , Time Factors , TouchABSTRACT
Parkinson's disease (PD) is characterized by a reduction in the number of dopaminergic neurons of the substantia nigra (SNpc), accompanied by motor and non-motor deficiencies such as respiratory failure. Here, our aim was to investigate possible neuronal communications between the SNpc and chemoreceptor neurons within the retrotrapezoid nucleus (RTN), in order to explain neurodegeneration and the loss of breathing function in the 6-OHDA PD animal model. Male Wistar rats received tracer injections in the SNpc, RTN and periaqueductal gray (PAG) regions to investigate the projections between those regions. The results showed that neurons of the SNpc project to the RTN by an indirect pathway that goes through the PAG region. In different groups of rats, reductions in the density of neuronal markers (NeuN) and the number of catecholaminergic varicosities in PAG, as well as reductions in the number of CO2-activated PAG neurons with RTN projections, were observed in a 6-OHDA model of PD. Physiological experiments showed that inhibition of the PAG by bilateral injection of muscimol did not produce resting breathing disturbances but instead reduced genioglossus (GGEMG) and abdominal (AbdEMG) muscle activity amplitude induced by hypercapnia in control rats that were urethane-anesthetized, vagotomized, and artificially ventilated. However, in a model of PD, we found reductions in resting diaphragm muscle activity (DiaEMG) and GGEMG frequencies, as well as in hypercapnia-induced DiaEMG, GGEMG and AbdEMG frequencies and GGEMG and AbdEMG amplitudes. Therefore, we can conclude that there is an indirect pathway between neurons of the SNpc and RTN that goes through the PAG and that there is a defect of this pathway in an animal model of PD.
Subject(s)
Gray Matter/pathology , Neural Pathways/pathology , Parkinson Disease/pathology , Parkinson Disease/physiopathology , Periaqueductal Gray/pathology , Pulmonary Ventilation/physiology , Substantia Nigra/pathology , Animals , Chemoreceptor Cells/physiology , Disease Models, Animal , GABA Agonists/pharmacology , Glutamate Decarboxylase/metabolism , Gray Matter/metabolism , Hypercapnia/etiology , Male , Muscimol/pharmacology , Oxidopamine/toxicity , Parkinson Disease/etiology , Phosphopyruvate Hydratase/metabolism , Pulmonary Ventilation/drug effects , Rats , Rats, Wistar , Sympatholytics/toxicity , Tyrosine 3-Monooxygenase/metabolismABSTRACT
In rodents, the most representative component of maternal behavior that meets the purpose of newborn nutrition is the kyphotic posture. During this posture, the mother maintains a unique environment for the protection, thermal regulation and breast-feeding of the progeny. The aim of this study was to investigate possible deficiencies in the kyphotic posture of adult lactating dams with pre- and neonatal undernutrition evoked by their own pups suckling in a home-cage situation. Wistar dams that had been previously exposed to perinatal undernutrition were mated at 90days of age, and pregnancy was confirmed by vaginal smears. Before testing if the perinatal underfed dam affected behavior, pups were removed (4h), and both the maternal response and the kyphotic posture were video-recorded (1h) and analyzed at 4 and 12days of lactation. Pre- and post-test litter weight gain was obtained. To immunostain the caudal periaqueductal gray, the litter was separated from their dams 24h before suckling stimulation. The results showed that underfed dams significantly reduced the duration of high kyphosis by choosing unconventional postures (prone and partial kyphosis). The body weight of the F1 offspring was significantly reduced, and the underfed F0 dams showed reduced c-Fos immunostaining at the caudal periaqueductal gray. The findings showed that early underfed dams have deficiencies in the mechanisms underlying the kyphosis, possibly because the pups' cues to evoke this posture were suboptimal and/or because the dam expressed deficient nursing. The results suggest that the abnormal kyphotic posture may affect the mother-litter bonds and have long-term effects on neonatal brain functions.
Subject(s)
Lactation/physiology , Malnutrition/physiopathology , Maternal Nutritional Physiological Phenomena/physiology , Periaqueductal Gray/metabolism , Posture/physiology , Animals , Female , Lactation/metabolism , Male , Malnutrition/pathology , Maternal Behavior/physiology , Periaqueductal Gray/pathology , Proto-Oncogene Proteins c-fos/metabolism , Random Allocation , Rats, WistarABSTRACT
Transcranial direct current stimulation (tDCS) is an emerging, noninvasive technique of neurostimulation for treating pain. However, the mechanisms and pathways involved in its analgesic effects are poorly understood. Therefore, we investigated the effects of direct current stimulation (DCS) on thermal and mechanical nociceptive thresholds and on the activation of the midbrain periaqueductal gray (PAG) and the dorsal horn of the spinal cord (DHSC) in rats; these central nervous system areas are associated with pain processing. Male Wistar rats underwent cathodal DCS of the motor cortex and, while still under stimulation, were evaluated using tail-flick and paw pressure nociceptive tests. Sham stimulation and naive rats were used as controls. We used a randomized design; the assays were not blinded to the experimenter. Immunoreactivity of the early growth response gene 1 (Egr-1), which is a marker of neuronal activation, was evaluated in the PAG and DHSC, and enkephalin immunoreactivity was evaluated in the DHSC. DCS did not change the thermal nociceptive threshold; however, it increased the mechanical nociceptive threshold of both hind paws compared with that of controls, characterizing a topographical effect. DCS decreased the Egr-1 labeling in the PAG and DHSC as well as the immunoreactivity of spinal enkephalin. Altogether, the data suggest that DCS disinhibits the midbrain descending analgesic pathway, consequently inhibiting spinal nociceptive neurons and causing an increase in the nociceptive threshold. This study reinforces the idea that the motor cortex participates in the neurocircuitry that is involved in analgesia and further clarifies the mechanisms of action of tDCS in pain treatment.
Subject(s)
Nociception , Periaqueductal Gray/physiopathology , Transcranial Direct Current Stimulation , Animals , Electrodes , Hyperalgesia/pathology , Hyperalgesia/physiopathology , Hyperalgesia/therapy , Male , Periaqueductal Gray/pathology , Posterior Horn Cells/pathology , Rats , Rats, WistarABSTRACT
2-arachidonoylglycerol (2-AG) is an endogenous ligand of the cannabinoid CB1 receptor. This endocannabinoid and its hydrolyzing enzyme, monoacylglycerol lipase (MAGL), are present in encephalic regions related to psychiatric disorders, including the midbrain dorsolateral periaqueductal grey (dlPAG). The dlPAG is implicated in panic disorder and its stimulation results in defensive responses proposed as a model of panic attacks. The present work verified if facilitation of 2-AG signalling in the dlPAG counteracts panic-like responses induced by local chemical stimulation. Intra-dlPAG injection of 2-AG prevented panic-like response induced by the excitatory amino acid N-methyl-d-aspartate (NMDA). This effect was mimicked by the 2-AG hydrolysis inhibitor (MAGL preferring inhibitor) URB602. The anti-aversive effect of URB602 was reversed by the CB1 receptor antagonist, AM251. Additionally, a combination of sub-effective doses of 2-AG and URB602 also prevented NMDA-induced panic-like response. Finally, immunofluorescence assay showed a significant increase in c-Fos positive cells in the dlPAG after local administration of NMDA. This response was also prevented by URB602. These data support the hypothesis that 2-AG participates in anti-aversive mechanisms in the dlPAG and reinforce the proposal that facilitation of endocannabinoid signalling could be a putative target for developing additional treatments against panic and other anxiety-related disorders.
Subject(s)
Arachidonic Acids/metabolism , Endocannabinoids/metabolism , Glycerides/metabolism , Panic Disorder/drug therapy , Panic Disorder/metabolism , Periaqueductal Gray/drug effects , Periaqueductal Gray/metabolism , Animals , Biphenyl Compounds/pharmacology , Cannabinoid Receptor Antagonists/pharmacology , Disease Models, Animal , Dose-Response Relationship, Drug , Fluorescent Antibody Technique , Male , N-Methylaspartate , Panic Disorder/pathology , Periaqueductal Gray/pathology , Piperidines/pharmacology , Pyrazoles/pharmacology , Rats, Wistar , Receptor, Cannabinoid, CB1/antagonists & inhibitors , Receptor, Cannabinoid, CB1/metabolismABSTRACT
The mechanisms underlying the pronociceptive effect of paradoxical sleep deprivation (PSD) are not known. In this study, we asked whether PSD increases tonic nociception in the formalin test, decreases the antinociceptive effect of morphine administered into the periaqueductal gray matter (PAG), and disrupts endogenous descending pain modulation. PSD for either 24 or 48 h significantly increased formalin-induced nociception and decreased mechanical nociceptive paw withdrawal threshold. The maximal antinociceptive effect induced by morphine (0.9-9 nmol, intra-PAG) was significantly decreased by PSD. The administration of a low dose of the GABAA receptor antagonist, bicuculline (30-300 pmol, intra-PAG), decreased nociception in control rats, but not in paradoxical-sleep-deprived ones. Furthermore, the administration of the cholecystokinin (CCK) 2 receptor antagonist, YM022 (0.5-2 pmol) in the rostral ventral medulla (RVM), decreased nociception in paradoxical-sleep-deprived rats but not in control ones. While a dose of the CCK 2 receptor agonist, CCK-8 (8-24 pmol intra-RVM), increased nociception in control rats, but not in paradoxical-sleep-deprived ones. In addition, the injection of lidocaine (QX-314, 2%, intra-RVM) decreased nociception in sleep-deprived rats, but not in control rats, while the lesion of the dorsolateral funiculus prevented the pronociceptive effect of PSD. Finally, PSD significantly increased c-Fos expression in the RVM. Therefore, PSD increases pain independently of its duration or of the characteristic of the nociceptive stimulus and decreases morphine analgesia at the PAG. PSD appears to increase pain by decreasing descending pain inhibitory activity and by increasing descending pain facilitatory activity.
Subject(s)
Nociception , Pain/complications , Pain/physiopathology , Sleep Deprivation/complications , Sleep Deprivation/physiopathology , Animals , Bicuculline/pharmacology , Bicuculline/therapeutic use , Lidocaine/analogs & derivatives , Lidocaine/pharmacology , Male , Morphine/administration & dosage , Morphine/pharmacology , Motor Activity/drug effects , Nociception/drug effects , Pain/drug therapy , Pain Measurement , Periaqueductal Gray/drug effects , Periaqueductal Gray/metabolism , Periaqueductal Gray/pathology , Proto-Oncogene Proteins c-fos/metabolism , Rats, Wistar , Sleep Deprivation/drug therapyABSTRACT
AIM: Although periaqueductal grey matter activation is known to elicit respiratory and cardiovascular responses, the role of this midbrain area in the compensatory responses to hypoxia is still unknown. To test the participation of the periaqueductal grey matter in cardiorespiratory and thermal responses to hypoxia in adult male Wistar rats, we performed a chemical lesion of the dorsolateral/dorsomedial or the ventrolateral/lateral periaqueductal grey matter using ibotenic acid. METHODS: Pulmonary ventilation, mean arterial pressure, heart rate and body temperature were measured in unanaesthetized rats during normoxic and hypoxic exposure (5, 15, 30 min, 7% O2). RESULTS: An ibotenic acid lesion of the dorsolateral/dorsomedial periaqueductal grey matter caused a higher increase in pulmonary ventilation (67.1%, 1730±282.5 mL kg(-1) min(-1)) compared to the Sham group (991.4±194 mL kg(-1) min(-1)) after 15 min in hypoxia, whereas for the ventrolateral/Lateral periaqueductal grey matter lesion, no differences were observed between groups. Mean arterial pressure, heart rate and body temperature were not affected by a dorsolateral/dorsomedial or ventrolateral/lateral periaqueductal grey matter lesion. CONCLUSION: Middle to caudal portions of the dorsolateral/dorsomedial periaqueductal grey matter neurones modulate the hypoxic ventilatory response, exerting an inhibitory modulation during low O2 situations. In addition, the middle to caudal portions of the dorsolateral/dorsomedial or ventrolateral/lateral periaqueductal grey matter do not appear to exert a tonic role on cardiovascular or thermal parameters during normoxic and hypoxic conditions.
Subject(s)
Hypoxia/physiopathology , Lung/innervation , Periaqueductal Gray/physiopathology , Pulmonary Ventilation , Animals , Arterial Pressure , Body Temperature Regulation , Carbon Dioxide/blood , Consciousness , Disease Models, Animal , Heart Rate , Hypoxia/blood , Ibotenic Acid/toxicity , Male , Oxygen/blood , Periaqueductal Gray/drug effects , Periaqueductal Gray/pathology , Pulmonary Ventilation/drug effects , Rats, Wistar , Reflex , Time FactorsABSTRACT
Dyspnea, hunger for air, and urge to flee are the cardinal symptoms of panic attacks. Patients also show baseline respiratory abnormalities and a higher rate of comorbid and antecedent respiratory diseases. Panic attacks are also precipitated by infusion of sodium lactate and inhalation of 5% CO2 in predisposed patients but not in healthy volunteers or patients without panic disorder. Accordingly, Klein [Klein (1993) Arch Gen Psychiatry 50:306-317] suggested that clinical panic is the misfiring of an as-yet-unidentified suffocation alarm system. In rats, selective anoxia of chemoreceptor cells by potassium cyanide (KCN) and electrical and chemical stimulations of periaqueductal gray matter (PAG) produce defensive behaviors, which resemble panic attacks. Thus, here we examined the effects of single or combined administrations of CO2 (8% and 13%) and KCN (10-80 µg, i.v.) on spontaneous and PAG-evoked behaviors of rats either intact or bearing electrolytic lesions of PAG. Exposure to CO2 alone reduced grooming while increased exophthalmus, suggesting an arousal response to non-visual cues of environment. Unexpectedly, however, CO2 attenuated PAG-evoked immobility, trotting, and galloping while facilitated defecation and micturition. Conversely, KCN produced all defensive behaviors of the rat and facilitated PAG-evoked trotting, galloping, and defecation. There were also facilitatory trends in PAG-evoked exophthalmus, immobility, and jumping. Moreover, whereas the KCN-evoked defensive behaviors were attenuated or even suppressed by discrete lesions of PAG, they were markedly facilitated by CO2. Authors suggest that the PAG harbors an anoxia-sensitive suffocation alarm system which activation precipitates panic attacks and potentiates the subject responses to hypercapnia.
Subject(s)
Asphyxia/pathology , Periaqueductal Gray/pathology , Periaqueductal Gray/physiopathology , Analysis of Variance , Animals , Behavior, Animal , Carbon Dioxide/adverse effects , Cyanates/pharmacology , Disease Models, Animal , Dose-Response Relationship, Drug , Electric Stimulation , Escape Reaction/drug effects , Escape Reaction/physiology , Freezing Reaction, Cataleptic/drug effects , Freezing Reaction, Cataleptic/physiology , Logistic Models , Male , Periaqueductal Gray/drug effects , Rats , Rats, WistarABSTRACT
The evolutionary approach to human anxiety is based on the defensive responses that nonhuman animals show to fear-provoking stimuli. Studies performed mostly on rodents have related areas such as the medial prefrontal cortex, amygdaloid and hypothalamic nuclei, hipoccampal formation, and midbrain central gray to these responses. It is clear, however, that animals show different and sometimes opposite responses according to the threatening stimulus. These responses include immediate reactions such as freezing or flight, behavioral inhibition or avoidance, which are organized by at least partially distinct brain systems. As discussed in this chapter, several pieces of evidence indicate that these brain systems are similar in rodents and primates. In addition, recent neuroimaging studies also suggest dysfunctions in these systems are probably related to anxiety disorders in humans.
Subject(s)
Anxiety/pathology , Anxiety/physiopathology , Avoidance Learning , Brain/pathology , Brain/physiopathology , Fear/psychology , Inhibition, Psychological , Amygdala/pathology , Amygdala/physiopathology , Animals , Anxiety/psychology , Escape Reaction , Hippocampus/pathology , Hippocampus/physiopathology , Humans , Hypothalamus/pathology , Hypothalamus/physiopathology , Neuropsychological Tests , Periaqueductal Gray/pathology , Periaqueductal Gray/physiopathology , Prefrontal Cortex/pathology , Prefrontal Cortex/physiopathology , Reflex, StartleABSTRACT
Polioencefalomalacia (PEM) de ruminantes é uma doença complexa. O termo indica um diagnóstico morfológico em que necrose neuronal grave resulta em amolecimento da substância cinzenta do cérebro. Interpretada no início como uma doença única, causada por deficiência de tiamina, acredita-se hoje que várias causas e diferentes mecanismos patogênicos, ou um único mecanismo patogênico disparado por diferentes agentes, sejam responsáveis pelo aparecimento da doença. Neste artigo, as possíveis causas e a patogênese de PEM em ruminantes são criticamente revisadas e discutidas. Também são revisadas a epidemiologia, os sinais clínicos, os achados macro e microscópicos e os métodos de diagnóstico, tratamento e controle.(AU)
Polioencephalomalacia (PEM) of ruminants is a complex disease. The term indicates a morphological diagnosis where severe neuronal necrosis results in softening of cerebral grey matter. Initially though as a single disease caused by thiamine deficiency, PEM is currently believe to have several causes and different pathogenic mechanisms or a single pathogenic organism triggered by different agents are responsible for the disease. In this paper the possible causes and pathogenesis of PEM in ruminants are critically reviewed and discussed. Also are reviewed the epidemiology, clinical signs, gross and histological findings, methods of diagnosis, treatment and control.(AU)
Subject(s)
Animals , Cattle , Cattle Diseases/etiology , Necrosis/pathology , Periaqueductal Gray/anatomy & histology , Periaqueductal Gray/pathology , Nervous System Diseases/diagnosis , Nervous System Diseases/veterinary , Ruminants/physiology , Cattle Diseases/epidemiology , Cattle Diseases/diagnosis , Neurophysiology/methodsABSTRACT
Polioencefalomalacia (PEM) de ruminantes é uma doença complexa. O termo indica um diagnóstico morfológico em que necrose neuronal grave resulta em amolecimento da substância cinzenta do cérebro. Interpretada no início como uma doença única, causada por deficiência de tiamina, acredita-se hoje que várias causas e diferentes mecanismos patogênicos, ou um único mecanismo patogênico disparado por diferentes agentes, sejam responsáveis pelo aparecimento da doença. Neste artigo, as possíveis causas e a patogênese de PEM em ruminantes são criticamente revisadas e discutidas. Também são revisadas a epidemiologia, os sinais clínicos, os achados macro e microscópicos e os métodos de diagnóstico, tratamento e controle.
Polioencephalomalacia (PEM) of ruminants is a complex disease. The term indicates a morphological diagnosis where severe neuronal necrosis results in softening of cerebral grey matter. Initially though as a single disease caused by thiamine deficiency, PEM is currently believe to have several causes and different pathogenic mechanisms or a single pathogenic organism triggered by different agents are responsible for the disease. In this paper the possible causes and pathogenesis of PEM in ruminants are critically reviewed and discussed. Also are reviewed the epidemiology, clinical signs, gross and histological findings, methods of diagnosis, treatment and control.
Subject(s)
Animals , Cattle , Nervous System Diseases/diagnosis , Nervous System Diseases/veterinary , Cattle Diseases/etiology , Necrosis/pathology , Periaqueductal Gray/anatomy & histology , Periaqueductal Gray/pathology , Cattle Diseases/diagnosis , Cattle Diseases/epidemiology , Neurophysiology/methods , RuminantsABSTRACT
Data from studies with humans have suggested that abnormalities of midbrain structures, including the periaqueductal gray matter (PAG), could be involved in the neurobiology of panic disorder (PD). The electrical stimulation of the PAG in neurosurgical patients induces panic-like symptoms and the effect of drugs that are effective in the treatment of PD in the simulation of public speaking model of anxiety is in agreement with data from animal models of PD. Structural neuroimaging studies have shown increases in gray matter volume of midbrain and pons of PD patients. There is also evidence of lower serotonin transporter and receptor binding, and increases of metabolism in the midbrain of PD patients. Nevertheless, these midbrain abnormalities can not be considered as specific findings, since neuroimaging data indicate that PD patients have abnormalities in other brain structures that process fear and anxiety.
Subject(s)
Panic Disorder/physiopathology , Periaqueductal Gray/physiopathology , Animals , Anxiety/physiopathology , Disease Models, Animal , Electric Stimulation , Humans , Models, Biological , Panic/physiology , Panic Disorder/pathology , Periaqueductal Gray/pathology , Serotonin/metabolismABSTRACT
Antidepressant treatment attenuates behavioral changes induced by uncontrollable stress. The periaqueductal gray matter (PAG) is proposed to be a brain site involved in the behavioral responses to uncontrollable stress and antidepressant effects. The main goal of the present study was to investigate the effect of antidepressant treatment on the pattern of neural activation of the PAG along its mediolateral and rostrocaudal subregions after a forced swim stress episode. Male Wistar rats were sub-acutely treated with desipramine (a selective noradrenaline re-uptake blocker, three injections of 10 mg/kg in 24 h) or clomipramine (a non-selective serotonin and noradrenaline re-uptake blocker, three injections of 10 mg/kg in 24 h) and submitted to the forced swimming test (FST). Two hours after the test their brain were removed for Fos immunohistochemistry. Fos-like immunoreactivity (FLI) in rostral, intermediate and caudal portions of dorsomedial (dmPAG), dorsolateral (dlPAG), lateral (lPAG) and ventrolateral (vlPAG) PAG were quantified by a computerized system. The FST session increased FLI in most parts of the PAG. Previous treatment with desipramine or clomipramine reduced FLI in all columns of the PAG. FLI in the PAG correlated positively with to the immobility time and negatively with to climbing behavior scored during the test. These results indicate that neurons in the PAG are activated by uncontrollable stress. Moreover, inhibitory action of antidepressants on this activity may be associated with the anti-immobility effects of these drugs in the FST.
Subject(s)
Antidepressive Agents/therapeutic use , Clomipramine/therapeutic use , Desipramine/therapeutic use , Oncogene Proteins v-fos/metabolism , Periaqueductal Gray/drug effects , Stress, Psychological/drug therapy , Analysis of Variance , Animals , Cell Count/methods , Disease Models, Animal , Immobility Response, Tonic/drug effects , Male , Periaqueductal Gray/pathology , Rats , Rats, Wistar , Stress, Psychological/etiology , Swimming/psychologyABSTRACT
INTRODUCTION: Chronic daily headache (CDH) is a chronic painful clinical condition that is frequently found in neurological practice. Diagnosis is clinical and the therapeutic approach is complex. Its mechanism of production is still not altogether clear, but a genetic component is acknowledged as a predisposing factor. Numerous areas are involved in the generation of primary headaches, including the periaqueductal grey matter (PAGM), which plays a role as a neuromodulator both in headaches and in other chronic painful conditions. AIMS: In order to evaluate possible biochemical changes in patients with CDH, magnetic resonance imaging was used to study the spectra produced in the PAGM. SUBJECTS AND METHODS: The spectra in the PAGM were studied in 17 patients with CDH. These were compared with the average spectra in 17 healthy subjects by means of differential spectroscopy. RESULTS: Subjects with CDH show a reduction of over 70% in the level of the metabolite N-acetyl-aspartyl-glutamate (NAAG) in the PAGM. NAAG is a peptide involved in antinociceptive activity. CONCLUSIONS: The reduction of NAAG in the PAGM suggests altered neuromodulation of the antinociceptive systems in subjects with CDH. Whether CDH is the cause or the consequence has still to be determined.
Subject(s)
Headache Disorders/physiopathology , Pain/physiopathology , Periaqueductal Gray/metabolism , Adult , Dipeptides/metabolism , Female , Headache Disorders/metabolism , Headache Disorders/pathology , Humans , Magnetic Resonance Imaging , Middle Aged , Neuroprotective Agents/metabolism , Periaqueductal Gray/anatomy & histology , Periaqueductal Gray/pathologyABSTRACT
Previous studies suggested a role for the rostral lateral periaqueductal gray (PAG) in the inhibition of maternal behavior induced by low doses of morphine in dams with previous morphine experience. In the present study, we first showed that unilateral NMDA lesions placed in this particular PAG region prevented the morphine-induced inhibition of maternal behavior in previously morphine-sensitized dams. As suggested by previous Fos data on the PAG, predatory hunting appears as a likely candidate to replace maternal behavior in the morphine-treated dams. By testing saline- and morphine-treated dams with live cockroaches only, we have presently shown that morphine challenge increased insect hunting. Moreover, morphine- and saline-treated dams were also observed in an environment containing pups and roaches. Although most of the saline-treated animals displayed active nursing and only occasionally presented insect hunting, all of the morphine-treated animals ignored the pups and avidly pursued and caught the roaches. We next questioned whether the rostral lateral PAG would be involved in this behavioral switch. Our results showed that unilateral lesions of the rostral lateral PAG, but not other parts of the PAG, partially impaired predatory hunting and restored part of the maternal response. Moreover, bilateral lesions of the rostral lateral PAG produced even more dramatic effects in inhibiting insect hunting and restoring maternal behavior. The present findings indisputably show that the rostral lateral PAG influences switching from maternal to hunting behavior in morphine-treated dams, thus supporting a previously unsuspected role for the PAG in selecting adaptive behavioral responses.
Subject(s)
Adaptation, Psychological/physiology , Behavior, Animal/physiology , Maternal Behavior/physiology , Periaqueductal Gray/physiology , Adaptation, Psychological/drug effects , Animals , Animals, Newborn , Behavior, Animal/drug effects , Female , Functional Laterality , Inhibition, Psychological , Male , Maternal Behavior/drug effects , Morphine/administration & dosage , N-Methylaspartate/toxicity , Narcotics/administration & dosage , Periaqueductal Gray/injuries , Periaqueductal Gray/pathology , Predatory Behavior/drug effects , Predatory Behavior/physiology , Pregnancy , Prenatal Exposure Delayed Effects , RatsABSTRACT
It has been shown that electrical stimulation of the central nucleus of the inferior colliculus (IC) at freezing or escape thresholds activates different neural circuits in the brain. Since electrical stimulation activates cell bodies and fibers of passage it is necessary to use chemical stimulation that activates only post-synaptic receptors. To examine this issue in more detail, we took advantage of the fact that GABAergic neurons exert tonic control over the neural substrates of aversion in the IC. Reduction of GABA transmission in this structure was performed with the use of semicarbazide - an inhibitor of the GABA synthesizing enzyme glutamic acid decarboxylase (GAD) - and the GABA-A receptor antagonist bicuculline. Depending on the dose employed local infusions of semicarbazide (6.0 microg/0.2 microl) or bicuculline (40 ng/0.2 microl) into this region caused freezing and escape, respectively. The results obtained showed that freezing behavior induced by semicarbazide was associated with an increase in Fos expression in the dorsomedial column of the PAG (dmPAG) only, while bicuculline-induced escape was related to widespread increase in Fos labeling, notably in the periaqueductal gray, hypothalamus nuclei, amygdaloid nuclei, the laterodorsal nucleus of thalamus (LD), the cuneiform nucleus (CnF) and the locus coeruleus (LC). Thus, the present data support the notion that freezing and escape behaviors induced by GABA blockade in the IC are neurally segregated: acquisition of aversive information of acoustic nature from the IC probably uses the dmPAG column as a relay station to higher brain centers whereas bicuculline-induced escape activates structures involved in both sensory processing and motor output of defensive behavior. These results support the existence of distinct neural circuits mediating the sensory and motor responses of the defense reaction. The extent of the brain activation during freezing appears to be limited to the anatomical connections of the dmPAG, whereas an overall activation of the limbic system predominates during escape behavior induced by IC stimulation.
Subject(s)
Brain/drug effects , Escape Reaction/drug effects , GABA-A Receptor Antagonists , Glutamate Decarboxylase/antagonists & inhibitors , Inferior Colliculi/drug effects , Motor Activity/drug effects , Proto-Oncogene Proteins c-fos/analysis , Animals , Bicuculline/analogs & derivatives , Bicuculline/pharmacology , Brain/pathology , Brain Mapping , Dose-Response Relationship, Drug , Escape Reaction/physiology , Glutamate Decarboxylase/physiology , Inferior Colliculi/pathology , Male , Microinjections , Motor Activity/physiology , Nerve Net/drug effects , Nerve Net/pathology , Neurons/diagnostic imaging , Neurons/drug effects , Periaqueductal Gray/drug effects , Periaqueductal Gray/pathology , Rats , Rats, Wistar , Receptors, GABA-A/physiology , Semicarbazides/pharmacology , UltrasonographyABSTRACT
In the rat experimental model, molar tooth movement induced by Waldo's method is known to cause a temporally and spatially defined pattern of brain neuronal activation. Since orthodontic correction usually involves the entire dental arch, we used a spring-activated appliance to extend the investigation to incisors, and we included brain regions related to antinociception. Adjustment of the non-activated appliance on incisors resulted in c-fos expression in the dorsal raphe, peri-aqueductal gray matter, and the locus coeruleus, in addition to trigeminal sensory subnuclei and the parabrachial nucleus, where neuronal activation has already been detected in previous studies on molar tooth movement. Appliance activation with a 70-g force resulted in a further increase in Fos-immunoreactive neurons in the trigeminal sensory subnucleus caudalis and in the dorsal raphe. This result suggests that there is a recruitment of neurons related to nociception and to antinociception when tooth movement is increased.
Subject(s)
Brain/metabolism , Genes, fos/genetics , Incisor/pathology , Proto-Oncogene Proteins c-fos/analysis , Tooth Movement Techniques , Analgesics/pharmacology , Animals , Brain/pathology , Genes, fos/drug effects , Ketamine/pharmacology , Locus Coeruleus/metabolism , Locus Coeruleus/pathology , Male , Models, Animal , Neurons/metabolism , Neurons/ultrastructure , Nociceptors/metabolism , Nociceptors/ultrastructure , Orthodontic Appliances , Pain/genetics , Periaqueductal Gray/metabolism , Periaqueductal Gray/pathology , Proto-Oncogene Proteins c-fos/drug effects , Rats , Rats, Wistar , Recruitment, Neurophysiological/genetics , Reticular Formation/metabolism , Reticular Formation/pathology , Tooth Movement Techniques/instrumentation , Trigeminal Nuclei/metabolism , Trigeminal Nuclei/pathology , Xylazine/pharmacologyABSTRACT
Hombre de 55 años que empezó con fatiga, alteraciones de su comportamiento y pérdida de memoria. En seguida, la familia notó ataxia, movimientos coreoatetósicos y espasticidad. La demencia se vilvió evidente en seis meses y a los 14 meses, el paciente estaba encamado, caquéctico y totalmente dependiente de su familia. El paciente fué sometido a una tomografia axial computada, que fué normal. Se realizó biopsia cerabral